Compare Medtronic PLC (MDT) vs Monster Beverage Corp (MNST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Monster Beverage Corp — how do they compare? Medtronic PLC trades at $88.85 (market cap $112.24B), while Monster Beverage Corp trades at $43.7 (market cap $85.51B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays a 3.28% dividend while Monster Beverage Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Monster Beverage Corp for 72 Days on average.
| MDT | MNST | |
|---|---|---|
Market Cap | $112.24B | $85.51B |
Volume | 105,663,236 | 8,569,709 |
Sector | Health | Consumer Staples |
52-Week High | $105.35 | $49.97 |
52-Week Low | $73.75 | $33.16 |
Typical Hold Time | 63 Days | 72 Days |
Enterprise Value | $131.58B | $83.81B |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $85.51, down 1.81% on the day, with the stock showing bearish technical signals despite strong fundamental performance. The company has beaten earnings expectations for three consecutive quarters, maintains a healthy 13.93% net income margin, and offers a solid 3.2% dividend yield with 49 consecutive years of dividend growth. Recent positive developments include FDA clearances for new medical technologies and raised full-year guidance.
MDT presents a compelling value opportunity with analyst consensus pointing to 14% upside to the $97.80 price target. The stock's current valuation multiples (P/E 21.61, P/S 3.01) appear reasonable given the company's stable revenue growth and strong cash flow generation. Key risks include increasing debt levels and competitive pressures in the medical device sector, but the company's dividend aristocrat status and improving operational performance support a positive long-term outlook.
Monster Beverage (MNST) trades at $42.88, down 0.86% on the day, with a bearish technical signal from moving averages. The company reported strong fundamentals: Q2 2026 EPS of $0.30 beat estimates, revenue grew to $8.29 billion in 2025, and net income margin stands at 23.08%. A 1:2 stock split is scheduled for August 11, 2026. Analyst consensus is a 'Buy' with a $98.22 price target, but technical indicators show selling pressure near current levels.
The outlook for MNST is mixed: robust earnings growth and zero long-term debt support upside, but high valuation ratios (P/E of 40.42) and bearish technicals pose near-term risks. International expansion, particularly a 35% sales surge overseas, offers growth potential, though regulatory challenges in markets like India and inflation pressures could hinder performance. The stock's rich pricing requires sustained execution to justify further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Monster Beverage Corp
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →
